76 related articles for article (PubMed ID: 26238155)
1. Expression profile of parkin isoforms in human gliomas.
Maugeri G; D'Amico AG; Magro G; Salvatorelli L; Barbagallo GM; Saccone S; Drago F; Cavallaro S; D'Agata V
Int J Oncol; 2015 Oct; 47(4):1282-92. PubMed ID: 26238155
[TBL] [Abstract][Full Text] [Related]
2. Expression pattern of parkin isoforms in lung adenocarcinomas.
D'Amico AG; Maugeri G; Magro G; Salvatorelli L; Drago F; D'Agata V
Tumour Biol; 2015 Jul; 36(7):5133-41. PubMed ID: 25656612
[TBL] [Abstract][Full Text] [Related]
3. Parkin pathway activation mitigates glioma cell proliferation and predicts patient survival.
Yeo CW; Ng FS; Chai C; Tan JM; Koh GR; Chong YK; Koh LW; Foong CS; Sandanaraj E; Holbrook JD; Ang BT; Takahashi R; Tang C; Lim KL
Cancer Res; 2012 May; 72(10):2543-53. PubMed ID: 22431710
[TBL] [Abstract][Full Text] [Related]
4. Glioma tumor grade correlates with parkin depletion in mutant p53-linked tumors and results from loss of function of p53 transcriptional activity.
Viotti J; Duplan E; Caillava C; Condat J; Goiran T; Giordano C; Marie Y; Idbaih A; Delattre JY; Honnorat J; Checler F; Alves da Costa C
Oncogene; 2014 Apr; 33(14):1764-75. PubMed ID: 23644658
[TBL] [Abstract][Full Text] [Related]
5. Differential expression of PARK2 splice isoforms in an in vitro model of dopaminergic-like neurons exposed to toxic insults mimicking Parkinson's disease.
La Cognata V; Maugeri G; D'Amico AG; Saccone S; Federico C; Cavallaro S; D'Agata V
J Cell Biochem; 2018 Jan; 119(1):1062-1073. PubMed ID: 28688199
[TBL] [Abstract][Full Text] [Related]
6. Down-regulation of Nedd4L is associated with the aggressive progression and worse prognosis of malignant glioma.
He S; Deng J; Li G; Wang B; Cao Y; Tu Y
Jpn J Clin Oncol; 2012 Mar; 42(3):196-201. PubMed ID: 22217575
[TBL] [Abstract][Full Text] [Related]
7. Carboxyl terminus of Hsp70-interacting protein (CHIP) contributes to human glioma oncogenesis.
Xu T; Zhou Q; Zhou J; Huang Y; Yan Y; Li W; Wang C; Hu G; Lu Y; Chen J
Cancer Sci; 2011 May; 102(5):959-66. PubMed ID: 21272160
[TBL] [Abstract][Full Text] [Related]
8. Proteomic Analysis of Parkin Isoforms Expression in Different Rat Brain Areas.
D'Amico AG; Maugeri G; Reitano R; Cavallaro S; D'Agata V
Protein J; 2016 Oct; 35(5):354-362. PubMed ID: 27601173
[TBL] [Abstract][Full Text] [Related]
9. Sphingosine-1-phosphate receptor type 1 regulates glioma cell proliferation and correlates with patient survival.
Yoshida Y; Nakada M; Sugimoto N; Harada T; Hayashi Y; Kita D; Uchiyama N; Hayashi Y; Yachie A; Takuwa Y; Hamada J
Int J Cancer; 2010 May; 126(10):2341-52. PubMed ID: 19810093
[TBL] [Abstract][Full Text] [Related]
10. Expression of the Ets-1 transcription factor in human astrocytomas is associated with Fms-like tyrosine kinase-1 (Flt-1)/vascular endothelial growth factor receptor-1 synthesis and neoangiogenesis.
Valter MM; Hügel A; Huang HJ; Cavenee WK; Wiestler OD; Pietsch T; Wernert N
Cancer Res; 1999 Nov; 59(21):5608-14. PubMed ID: 10554042
[TBL] [Abstract][Full Text] [Related]
11. In vivo expression of insulin-like growth factor-binding protein-2 in human gliomas increases with the tumor grade.
Elmlinger MW; Deininger MH; Schuett BS; Meyermann R; Duffner F; Grote EH; Ranke MB
Endocrinology; 2001 Apr; 142(4):1652-8. PubMed ID: 11250947
[TBL] [Abstract][Full Text] [Related]
12. Reduction of Akt2 inhibits migration and invasion of glioma cells.
Zhang B; Gu F; She C; Guo H; Li W; Niu R; Fu L; Zhang N; Ma Y
Int J Cancer; 2009 Aug; 125(3):585-95. PubMed ID: 19330838
[TBL] [Abstract][Full Text] [Related]
13. Integrated analysis of genome-wide DNA methylation, gene expression and protein expression profiles in molecular subtypes of WHO II-IV gliomas.
Wang ZL; Zhang CB; Cai JQ; Li QB; Wang Z; Jiang T
J Exp Clin Cancer Res; 2015 Oct; 34():127. PubMed ID: 26502731
[TBL] [Abstract][Full Text] [Related]
14. Related to testes-specific, vespid, and pathogenesis protein-1 (RTVP-1) is overexpressed in gliomas and regulates the growth, survival, and invasion of glioma cells.
Rosenzweig T; Ziv-Av A; Xiang C; Lu W; Cazacu S; Taler D; Miller CG; Reich R; Shoshan Y; Anikster Y; Kazimirsky G; Sarid R; Brodie C
Cancer Res; 2006 Apr; 66(8):4139-48. PubMed ID: 16618735
[TBL] [Abstract][Full Text] [Related]
15. RIZ1: a potential tumor suppressor in glioma.
Zhang C; Zhu Q; He H; Jiang L; Qiang Q; Hu L; Hu G; Jiang Y; Ding X; Lu Y
BMC Cancer; 2015 Dec; 15():990. PubMed ID: 26690953
[TBL] [Abstract][Full Text] [Related]
16. Expression of p27KIP1 in human gliomas: relationship between tumor grade, proliferation index, and patient survival.
Zagzag D; Blanco C; Friedlander DR; Miller DC; Newcomb EW
Hum Pathol; 2003 Jan; 34(1):48-53. PubMed ID: 12605366
[TBL] [Abstract][Full Text] [Related]
17. Enhancer of Zeste 2 (EZH2) is up-regulated in malignant gliomas and in glioma stem-like cells.
Orzan F; Pellegatta S; Poliani PL; Pisati F; Caldera V; Menghi F; Kapetis D; Marras C; Schiffer D; Finocchiaro G
Neuropathol Appl Neurobiol; 2011 Jun; 37(4):381-94. PubMed ID: 20946108
[TBL] [Abstract][Full Text] [Related]
18. Expression of osteopontin in human glioma. Its correlation with the malignancy.
Saitoh Y; Kuratsu J; Takeshima H; Yamamoto S; Ushio Y
Lab Invest; 1995 Jan; 72(1):55-63. PubMed ID: 7837791
[TBL] [Abstract][Full Text] [Related]
19. Protein tyrosine phosphatase receptor U (PTPRU) is required for glioma growth and motility.
Zhu Z; Liu Y; Li K; Liu J; Wang H; Sun B; Xiong Z; Jiang H; Zheng J; Hu Z
Carcinogenesis; 2014 Aug; 35(8):1901-10. PubMed ID: 24876153
[TBL] [Abstract][Full Text] [Related]
20. Cloning and characterization of human RTVP-1b, a novel splice variant of RTVP-1 in glioma cells.
Xiang C; Sarid R; Cazacu S; Finniss S; Lee HK; Ziv-Av A; Mikkelsen T; Brodie C
Biochem Biophys Res Commun; 2007 Oct; 362(3):612-8. PubMed ID: 17825796
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]